PATENT CLAIM ANALYSIS

Application Number: 16012961
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["424", "452000"]

Abstract:
Described herein are oral pharmaceutical compositions comprising liquid dosage forms of sodium naproxen in soft gel capsules. In one embodiment, the pharmaceutical composition comprises sodium naproxen, 0.2-1.0 mole equivalents of a de-ionizing agent per mole of naproxen, polyethylene glycol, and one or more solubilizers such as propylene glycol, polyvinyl pyrrolidone or a combination thereof.

Claim (Index 9):
The capsule of  claim 1 , wherein the fill material is liquid.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 94.0
- Lexical Diversity: 1.35556
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15591512', '15159972', '14977808', '13543244', '10984205']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7817142088772615
- 35 USC 102 Novelty (BERT): 0.5447233067261428
- Combined Prediction Score: 0.7580151186621497
- Mean Citation Score: 346.887406
- Max Citation Score: 407.33008
- Similarity Product: 289.86859078374863

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test